SEC Form 4 · accession 0001635493-26-000002
Cardiff Oncology, Inc. · CRDF
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lale White
Director
Period of report
Jun 11, 2026
Accepted (ET)
Jun 15, 2026 · 9:30 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001213037
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options | $1.59 | Jun 11, 2026 | A | 40,565 | A | Jun 11, 2027 | Jun 11, 2036 | Common Stock | 40,565 | 199,246 | D |